| |
| | AL 721 Today - AIDS Treatment News |
 | | AL 721 was developed at The Weizmann Institute of Science, Rehovot, Israel, by a team led by Meir Shinitzky, Ph.D., a cancer researcher there. |
 | | Because AL 721 is patented (U.S. patent #4,474,773, "Lipid Fraction for Treating Disease", October 2, 1984) and unavailable from the patent holder, physicians cannot be involved without bending or breaking the rules--unless they happen to be working in the only existing official trial, with the handful of patients at St. Luke's/ Roosevelt. |
 | | Promising treatments like AL 721 will continue to be underground medicine until physicians, activists, and others have the courage and commitment to look at the evidence, make informed, independent decisions, and speak and act accordingly. |
| www.aids.org /atn/a-042-02.html (2821 words) |
|